Debra Stephanie Barker, Interim Chief Executive Officer at Destiny Pharma plc, holds 88.46K shares in Destiny Pharma plc (Ticker: GB:DEST), holds 50.00K shares in Arix Bioscience (Ticker: DE:3HY). Most recently, Debra Stephanie Barker Bought ― shares of Destiny Pharma plc on May 26, 2023 for an estimated value of 6.60K.
What was Debra Stephanie Barker’s latest transaction?
Debra Stephanie Barker latest transaction was an Informative Buy of 6.60K.
What was Debra Stephanie Barker's most profitable transaction?
Debra Stephanie Barker’s most profitable transaction was an Informative Buy of GB:DEST stock on November 10, 2020. The return on the trade was 88.30%.
What is Debra Stephanie Barker's role in Destiny Pharma plc?
Debra Stephanie Barker's role in Destiny Pharma plc is Interim Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.